The Hydration Pharmaceuticals Company Limited reported earnings results for the half year ended June 30, 2024. For the half year, the company reported sales was USD 4.97 million compared to USD 5.3 million a year ago. Net loss was USD 3.11 million compared to USD 3.53 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.02 a year ago. Diluted loss per share from continuing operations was USD 0.01 compared to USD 0.02 a year ago.
